Concepedia

Publication | Closed Access

Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alfa-2b in patients with advanced cancer.

DOI

39

Citations

34

References

1993

Year

L Danhauser, J. H. Freimann, T. L. Gilchrist, Jordan U. Gutterman, Cheri Y Hunter, Anita C. Yeomans, Avi B. Markowitz
Journal of Clinical Oncology

Abstract

rIFN-a reduces FUra Cl and, consequently, increases FUra-associated toxicity. Phase II studies of FUra and rIFN-a seem to be warranted.

References

YearCitations

Page 1